Naphthalene

Naphthalene

SCHEMBL7849032

c1ccc2ccccc2c1.c1ccc2ncccc2c1.c1ccc2ncncc2c1

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 7/20 0.77
ALDH1A1 P00352 5/20 0.65
PIK3CD O00329 1/20 0.51
PIK3CA P42336 1/20 0.51
NPC1 O15118 2/20 0.43
POLB P06746 1/20 0.42
RAB9A P51151 1/20 0.42
CYP2A6 P11509 1/20 0.42
CYP3A4 P08684 1/20 0.41
PDGFRB P09619 1/20 0.41
PDGFRA P16234 1/20 0.41
CASP1 P29466 2/20 0.40
HTT P42858 2/20 0.40
MEN1 O00255 1/20 0.40
CASP7 P55210 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
NR4A2 P43354 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinoline SCHEMBL156755 0.98 EGFR (0.80) EGFRALDH1A1PIK3CDPIK3CANPC1
Quinoline SCHEMBL27927382 0.96 EGFR (0.77) EGFRALDH1A1PIK3CDPIK3CANPC1
Isoquinoline SCHEMBL27889185 0.93 EGFR (0.67) EGFRALDH1A1PIK3CDPIK3CANPC1
Quinoline SCHEMBL27710462 0.93 EGFR (0.71) EGFRALDH1A1PIK3CDPIK3CANPC1
Quinoxaline SCHEMBL150387 0.88 EGFR (0.83) EGFRALDH1A1PIK3CDPIK3CANPC1
Quinazoline SCHEMBL22833783 0.88 EGFR (1.00) EGFRALDH1A1PIK3CDPIK3CACYP2A6
Quinazoline SCHEMBL29490398 0.88 EGFR (1.00) EGFRALDH1A1PIK3CDPIK3CACYP2A6
Quinazoline SCHEMBL29356169 0.88 EGFR (1.00) EGFRALDH1A1PIK3CDPIK3CACYP2A6
Quinazoline SCHEMBL5920 0.88 EGFR (1.00) EGFRALDH1A1PIK3CDPIK3CACYP2A6
Quinazoline SCHEMBL28109843 0.86 EGFR (0.87) EGFRALDH1A1PIK3CDPIK3CANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077944-A1 CARBOXAMIDE COMPOUNDS, COMPOSITIONS, AND METHODS FOR INHIBITING PARP ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 2001-02-28 EP disclosed
WO-1999059973-A1 CARBOXAMIDE COMPOUNDS, COMPOSITIONS, AND METHODS FOR INHIBITING PARP ACTIVITY GUILFORD PHARMACEUTICALS INC. (US) 1999-11-25 WO disclosed